Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.2; the previous v3.2.0 tag was removed.
    Difference
    0.0%
    Check dated 2025-11-27T03:51:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice that previously warned users information may not be up to date and that NIH operations could be affected.
    Difference
    0.3%
    Check dated 2025-11-19T22:14:37.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Minor visual/layout adjustments and a more recent last-updated timestamp, with core study details unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-29T10:09:55.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a full Neoadjuvant/Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy study (SAKK 06/17), detailing objective, design, criteria, endpoints, and locations; no deletions were reported.
    Difference
    100%
    Check dated 2025-10-15T02:53:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated core page content to reflect a version bump to v3.2.0 and a government-operating-status notice; removed the previous v3.1.0 version tag.
    Difference
    3%
    Check dated 2025-10-07T23:18:18.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0; a minimal change primarily affecting the page's revision metadata.
    Difference
    0.1%
    Check dated 2025-09-30T02:50:57.000Z thumbnail image

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.